Latest blog articles
-
Not out of possibility, but out of necessity
-
Greece emerged as the EU’s poster child in the fight against Covid-19 during the first few months of the pandemic. Its approach, while effective, is not beyond reproach.
-
Continued disproportionate impact on daily life in the border region
With the circulation of the Coronavirus, governments are trying to restrict the movement of people.
-
The European Union (EU) budget is about one percent of the Gross Domestic Product (GDP) of all Member States amounting to about €240 per annum, per citizen. The EU budget redistributes more than €150 billion annually.
-
The ongoing COVID-19 pandemic is arguably one of the biggest crises of modern times. The conflict between the search for a vaccine, and the artificial scarcity created by patent law, has created a catch-22 situation. How will patent law apply to a vaccine under these circumstances?
-
During the European Council this week all eyes are, again, on the negotiations for the future European Union (EU) budget. Analysts tended to focus mainly on two things.
-
-
Several pharmaceutical companies all around the world, including in the European Union (EU), have been racing to find a treatment for the virus. Since these may be subject to patent rights, government intervention may be needed.
-
How do we guarantee access to COVID-19 vaccines and therapies, and secure health-related human rights for all? We’ve heard a string of promises in the race for new vaccines and therapies.
-
It feels sometimes as if the whole world of science is working exclusively on finding a cure for COVID-19.